Clinical Study
Prospective Multicentre Study on the Epidemiology and Current Therapeutic Management of Severe Bronchiolitis in Spain
Table 1
Epidemiological, family, and personal history characteristics of patients included in the BRUCIP study.
| Variable | Value |
| Sample size () | 262 patients | Sex (male/female) | 143 (54.6%)/119 (45.4%) | Age | 1 month (0–23 days) | Weight | 4.6 kg (1.4–14) | Stay in PICU | 7 days (1–46) | Total hospital stay | 11 days (3–59 days) | FH of smoking | 83 patients (31.7%) | FH of atopy | 66 patients (25.2%) | Breast-feeding for at least first 15 days of life | 145 patients (55.3%) | Risk factor for severity | 70 patients (26.7%) | (i) Premature | (i) 55 patients (21%) | (ii) Heart disease | (ii) 10 patients (3.81%) | (iii) Respiratory disease | (iii) 5 patients (1.90%) | (iv) Neuromuscular disease | (iv) 2 patients (0.8%) | Prophylaxis with palivizumab | 14 patients (5.3%) |
|
|
Median and range. FH: family history; PICU: paediatric intensive care unit.
|